Hypertension in Transgenic Mice With Brain-Selective Overexpression of the 2B-Adrenoceptor
Author(s) -
Ekaterina Kintsurashvili,
Sylvia Shenouda,
Deborah Ignacia D. Ona,
Livia Ona,
Shahzad Ahmad,
Katya Ravid,
Haralambos Gavras
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2008.314
Subject(s) - medicine , genetically modified mouse , adrenergic , adrenergic receptor , sympathetic nervous system , transgene , receptor , central nervous system , endocrinology , neuroscience , blood pressure , gene , genetics , biology
Previous studies have shown that the presynaptic alpha(2B)-adrenoceptor subtype in the central nervous system has a sympathoexcitatory function and its activation leads to a hyperadrenergic hypertensive state. The purpose of this project was to develop a novel hyperadrenergic model, a transgenic (TG) mouse model with brain-selective overexpression of the alpha(2B)-adrenergic receptor (alpha(2B)-AR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom